Late effects of pediatric cancer treatment come into sharper focus, predictive tests are emerging.
McNeil
Caroline
C
D000970:Antineoplastic Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008403:Mass Screening / Q000379:methods; D008594:Menopause, Premature / Q000187:drug effects / Q000528:radiation effects; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000517:prevention & control; D009765:Obesity / Q000209:etiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011322:Primary Prevention / Q000379:methods*; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D017741:Survivors; D013997:Time Factors
D000970:Antineoplastic Agents; D015415:Biomarkers